cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
3.1. Market Snapshot
3.2. Market Dynamics
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Growing prevalence of fungal infection due to climate
4.3.1.2. High awareness levels pertaining to myriad fungal infections
4.3.1.3. Increased demand for the drugs to combat the related diseases
4.3.1.4. Favorable government initiative and corporate funds
4.3.2. Restraints
4.3.2.1. Continued preference for conventional antifungal drugs
4.3.2.2. Growing population with antifungal drug resistance
4.3.3. Opportunities
4.3.3.1. Increased R&D funding and focus on product innovation
4.3.3.2. Patent expiration of branded drugs
4.3.4. Challenges
4.3.4.1. Potential side effects
4.3.4.2. Presence of counterfeit drugs and resistance toward antifungal drugs
5. Global Antifungal Drug Market, by Form
5.1. Ointments
5.1.1. Overview
5.1.2. Market Sizing & Forecasting
5.2. Powder
5.2.1. Overview
5.2.2. Market Sizing & Forecasting
5.3. Tablets
5.3.1. Overview
5.3.2. Market Sizing & Forecasting
6. Global Antifungal Drug Market, by Infection Type
6.1. Superficial Fungal Infection
6.1.1. Overview
6.1.2. Market Sizing & Forecasting
6.2. Systemic Fungal infection
6.2.1. Overview
6.2.2. Market Sizing & Forecasting
7. Global Antifungal Drug Market, by Therapeutic Indications
7.1. Aspergillosis
7.1.1. Overview
7.1.2. Market Sizing & Forecasting
7.2. Candidiasis
7.2.1. Overview
7.2.2. Market Sizing & Forecasting
7.3. Dermatophytosis
7.3.1. Overview
7.3.2. Market Sizing & Forecasting
8. Global Antifungal Drug Market, by Type
8.1. Allylamines
8.1.1. Overview
8.1.2. Market Sizing & Forecasting
8.1.3. Butenafine
8.1.4. Naftifine
8.1.5. Terbinafine
8.2. Azoles
8.2.1. Overview
8.2.2. Market Sizing & Forecasting
8.2.3. Imidazoles
8.2.4. Thiazoles
8.2.5. Voricanazole
8.3. Echinocandins
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Anidulafungin
8.3.4. Caspofungin
8.3.5. Micafungin
8.4. Polyenes
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Amphotericin B
8.4.4. Candicidin
8.4.5. Hamycin
8.4.6. Natamycin
9. Global Antifungal Drug Market, by Geography
9.1. Americas
9.1.1. Overview
9.1.2. Market Sizing & Forecasting
9.1.3. United States
9.2. Europe, Middle East & Africa
9.2.1. Overview
9.2.2. Market Sizing & Forecasting
9.2.3. United Kingdom
9.2.4. Germany
9.2.5. Saudi Arabia
9.3. Asia-Pacific
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. China
9.3.4. Japan
9.3.5. India
10. Competitive News Feed Analysis
11. Company Usability Profiles
11.1. Abbott Laboratories
11.1.1. Business Overview
11.1.2. Business Strategy
11.1.3. Business SWOT Analysis
11.2. Astellas Pharma Inc.
11.2.1. Business Overview
11.2.2. Business Strategy
11.2.3. Business SWOT Analysis
11.3. Bayer HealthCare Pharmaceuticals LLC
11.3.1. Business Overview
11.3.2. Business Strategy
11.3.3. Business SWOT Analysis
11.4. Enzon Pharmaceuticals, Inc.
11.4.1. Business Overview
11.4.2. Business Strategy
11.4.3. Business SWOT Analysis
11.5. Gilead Sciences, Inc.
11.5.1. Business Overview
11.5.2. Business Strategy
11.5.3. Business SWOT Analysis
11.6. GlaxoSmithKline plc
11.6.1. Business Overview
11.6.2. Business Strategy
11.6.3. Business SWOT Analysis
11.7. Kramer Laboratories, Inc.
11.7.1. Business Overview
11.7.2. Business Strategy
11.7.3. Business SWOT Analysis
11.8. Merck Group
11.8.1. Business Overview
11.8.2. Business Strategy
11.8.3. Business SWOT Analysis
11.9. Novartis AG
11.9.1. Business Overview
11.9.2. Business Strategy
11.9.3. Business SWOT Analysis
11.10. Pfizer, Inc.
11.10.1. Business Overview
11.10.2. Business Strategy
11.10.3. Business SWOT Analysis
11.11. SCYNEXIS, Inc.
11.11.1. Business Overview
11.11.2. Business Strategy
11.11.3. Business SWOT Analysis
11.12. Sanofi-Aventis SA
11.12.1. Business Overview
11.12.2. Business Strategy
11.12.3. Business SWOT Analysis
11.13. Sigma-Aldrich, Inc.
11.13.1. Business Overview
11.13.2. Business Strategy
11.13.3. Business SWOT Analysis
12. Appendix
12.1. Top Reports
12.2. Author Details

LIST OF TABLES (46 TABLES)

TABLE 1. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 2. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 6. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 7. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 8. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 10. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 13. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 19. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 20. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 21. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 22. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 23. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 29. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 30. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2016 - 2024 (USD BILLION)
TABLE 31. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2016 - 2024 (USD BILLION)
TABLE 32. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2016 - 2024 (USD BILLION)
TABLE 33. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)
TABLE 34. COMPETITIVE NEWS FEED ANALYSIS FOR ABBOTT LABORATORIES IN ANTIFUNGAL DRUG MARKET
TABLE 35. COMPETITIVE NEWS FEED ANALYSIS FOR ASTELLAS PHARMA INC. IN ANTIFUNGAL DRUG MARKET
TABLE 36. COMPETITIVE NEWS FEED ANALYSIS FOR BAYER HEALTHCARE PHARMACEUTICALS LLC IN ANTIFUNGAL DRUG MARKET
TABLE 37. COMPETITIVE NEWS FEED ANALYSIS FOR ENZON PHARMACEUTICALS, INC. IN ANTIFUNGAL DRUG MARKET
TABLE 38. COMPETITIVE NEWS FEED ANALYSIS FOR GILEAD SCIENCES, INC. IN ANTIFUNGAL DRUG MARKET
TABLE 39. COMPETITIVE NEWS FEED ANALYSIS FOR GLAXOSMITHKLINE PLC IN ANTIFUNGAL DRUG MARKET
TABLE 40. COMPETITIVE NEWS FEED ANALYSIS FOR KRAMER LABORATORIES, INC. IN ANTIFUNGAL DRUG MARKET
TABLE 41. COMPETITIVE NEWS FEED ANALYSIS FOR MERCK GROUP IN ANTIFUNGAL DRUG MARKET
TABLE 42. COMPETITIVE NEWS FEED ANALYSIS FOR NOVARTIS AG IN ANTIFUNGAL DRUG MARKET
TABLE 43. COMPETITIVE NEWS FEED ANALYSIS FOR PFIZER, INC. IN ANTIFUNGAL DRUG MARKET
TABLE 44. COMPETITIVE NEWS FEED ANALYSIS FOR SCYNEXIS, INC. IN ANTIFUNGAL DRUG MARKET
TABLE 45. COMPETITIVE NEWS FEED ANALYSIS FOR SANOFI-AVENTIS SA IN ANTIFUNGAL DRUG MARKET
TABLE 46. COMPETITIVE NEWS FEED ANALYSIS FOR SIGMA-ALDRICH, INC. IN ANTIFUNGAL DRUG MARKET

LIST OF FIGURES (64 TABLES)

FIGURE 1. GLOBAL ANTIFUNGAL DRUG MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL ANTIFUNGAL DRUG MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL ANTIFUNGAL DRUG MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL ANTIFUNGAL DRUG MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL ANTIFUNGAL DRUG MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL ANTIFUNGAL DRUG MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. ANTIFUNGAL DRUG MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL ANTIFUNGAL DRUG MARKET SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 12. GLOBAL ANTIFUNGAL DRUG MARKET SHARE, BY FORM, 2017 (%)
FIGURE 13. GLOBAL ANTIFUNGAL DRUG MARKET SHARE, BY INFECTION TYPE, 2017 (%)
FIGURE 14. GLOBAL ANTIFUNGAL DRUG MARKET SHARE, BY THERAPEUTIC INDICATIONS, 2017 (%)
FIGURE 15. GLOBAL ANTIFUNGAL DRUG MARKET SHARE, BY TYPE, 2017 (%)
FIGURE 16. GLOBAL ANTIFUNGAL DRUG MARKET: KEY MARKET DYNAMICS
FIGURE 17. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2016 - 2024 (USD BILLION)
FIGURE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 19. GLOBAL ANTIFUNGAL DRUG MARKET OPPORTUNITY ANALYSIS, BY GEOGRAPHY, 2024 (USD BILLION)
FIGURE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2017 (USD BILLION)
FIGURE 21. GLOBAL ANTIFUNGAL DRUG MARKET OPPORTUNITY ANALYSIS, BY FORM, 2024 (USD BILLION)
FIGURE 22. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2017 (USD BILLION)
FIGURE 23. GLOBAL ANTIFUNGAL DRUG MARKET OPPORTUNITY ANALYSIS, BY INFECTION TYPE, 2024 (USD BILLION)
FIGURE 24. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2017 (USD BILLION)
FIGURE 25. GLOBAL ANTIFUNGAL DRUG MARKET OPPORTUNITY ANALYSIS, BY THERAPEUTIC INDICATIONS, 2024 (USD BILLION)
FIGURE 26. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2017 (USD BILLION)
FIGURE 27. GLOBAL ANTIFUNGAL DRUG MARKET OPPORTUNITY ANALYSIS, BY TYPE, 2024 (USD BILLION)
FIGURE 28. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 29. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 30. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 31. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 32. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 33. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 34. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 35. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 36. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 37. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 38. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 39. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 40. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 41. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 42. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 43. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 44. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 45. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 46. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 47. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 48. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 49. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 50. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 51. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 52. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 53. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 55. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 56. GERMANY ANTIFUNGAL DRUG MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 57. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 58. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 59. CHINA ANTIFUNGAL DRUG MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 60. JAPAN ANTIFUNGAL DRUG MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 61. INDIA ANTIFUNGAL DRUG MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 62. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL ANTIFUNGAL DRUG MARKET, BY NEWS TYPE
FIGURE 63. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL ANTIFUNGAL DRUG MARKET, BY COMPANY
FIGURE 64. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL ANTIFUNGAL DRUG MARKET, BY YEAR

“Growing prevalence of fungal infection due to climate is one of the factors largely attributing to the growth of antifungal drug market globally”

The global antifungal drug market is expected to grow from USD 14.22 billion 2017 to USD 18.92 billion by the end of 2024, at a Compound Annual Growth Rate (CAGR) of 4.17%.

Market Segmentation & Coverage: The report on global antifungal drug market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the economies and geographies of the potential customer group can help to gain business acumen for better strategic decision making. Our market coverage across different industry verticals reveals the hidden truth about the strategies adopted by the players in different verticals and help the organization to decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.This research report categorizes the global antifungal drug market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Form
1. Ointments
2. Powder
3. Tablets

Based on Infection Type
1. Superficial Fungal Infection
2. Systemic Fungal infection

Based on Therapeutic Indications
1. Aspergillosis
2. Candidiasis
3. Dermatophytosis

Based on Type
1. Allylamines
2. Azoles
3. Echinocandins
4. Polyenes

Based on Geography
1. Americas (United States)
2. Europe, Middle East & Africa (United Kingdom, Germany, and Saudi Arabia)
3. Asia-Pacific (China, Japan, and India)

Company Usability Profiles:
The antifungal drug market research report provides the company usability profiles and analyze the business overview, business product offering, SWOT analysis, and business strategy of the following company:
1. Abbott Laboratories
2. Astellas Pharma Inc.
3. Bayer HealthCare Pharmaceuticals LLC
4. Enzon Pharmaceuticals, Inc.
5. Gilead Sciences, Inc.
6. GlaxoSmithKline plc
7. Kramer Laboratories, Inc.
8. Merck Group
9. Novartis AG
10. Pfizer, Inc.
11. SCYNEXIS, Inc.
12. Sanofi-Aventis SA
13. Sigma-Aldrich, Inc.

Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

Reasons to Buy:
1. To comprehensively understand of the antifungal drug market with respect to major influencing factor such as drivers, restraints, opportunities and challenges
2. To strategically analyze each vertical and geographic sub-segment in the antifungal drug market and its individual growth and its impact towards the growth of overall market




Summary:
Get latest Market Research Reports on Antifungal Drug Market. Industry analysis & Market Report on Antifungal Drug Market is a syndicated market report, published as The global antifungal drug market is expected to grow from USD 14.22 billion 2017 to USD 18.92 billion by the end of 2024, at a CAGR of 4.17%.. It is complete Research Study and Industry Analysis of Antifungal Drug Market market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$2,999.00
$3,999.00
$4,999.00
2,013.83
2,685.33
3,356.83
2,759.68
3,679.88
4,600.08
363,298.86
484,438.86
605,578.86
198,873.89
265,187.29
331,500.69
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report